Comparison of the efficacy between Bofutsushosan and Daisaikoto in sleep apnea patients complicated with persistent obese and hypertensio

Not Applicable

• Conditions: Obstructive sleep apnea syndrome, Hypertension, Obesity

• Registration Number: JPRN-UMIN000003981
• Lead Sponsor: Kyoto University,Graduate School of Medicine,Department of respiratory medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-15
• Study Completion: 2013-08-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 152

Inclusion Criteria

Not provided

Exclusion Criteria

1.Acute infectious diseases or malignant diseases 2.New onset of cerebrovascular infarctions or myocardial infarctions within 6 months 3.Interventions for coronary arteries within 6 months 4.Admission due to angina pectoris or heart diseases within 6 months 5.Severe heart failure (NYHA class 3 or 4) or severe arrythmia 6.Systolic BP>=160mmHg or Diastolic BP >=100mg. (We should try other usual antihypertensive drugs rather than chinese herbal medicines) 7.Allergic for Bofutsushosan or Daisaikoto 8.Taking other herbal medicines 9.Severe liver failiure or renal failure(including patiens undergoing dailysis) 9.Interstitial pneumonitis 10.Undergoing interferon treatment for hepatitis 11.Pregnancy 12.Judged as inappropriate by attending physicians

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in body weight

Secondary Outcome Measures

Name	Time	Method
Blood pressure,Visceral fat accumulation